PT Metro Healthcare Indonesia Tbk EBIT

PT Metro Healthcare Indonesia Tbk posts a EBIT of $110B as of June 2026. That compares with $37B in the prior-year period — up 212.3% year over year. That is below the sector sector average of $2.6T. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, PT Metro Healthcare Indonesia Tbk's EBIT was $37B. The latest reading is $110B — a 212.3% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

For its sector stocks, a EBIT near $2.6T is typical. PT Metro Healthcare Indonesia Tbk's $110B is lower that level. That is roughly 95.5% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

EBIT is one piece of PT Metro Healthcare Indonesia Tbk's financial statement story. At $110B, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for CARE.JK's EBIT usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $2.6T), and (3) consistency with growth and profitability. This page covers the first two; PT Metro Healthcare Indonesia Tbk's other metric pages and overview cover the third.